ITRM Iterum Therapeutics Plc

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Iterum Therapeutics Plc market cap is $23.67M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Iterum Therapeutics Plc 52 week high is $2.50 as of June 04, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Iterum Therapeutics Plc 52 week low is $0.622 as of June 04, 2024.

Iterum Therapeutics Plc stock price today is $1.43.

Iterum Therapeutics Plc stock price yesterday was $1.50.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Iterum Therapeutics Plc’s P/E ratio is -0.54.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Iterum Therapeutics Plc P/B ratio is -3.8297.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Iterum Therapeutics Plc's EBITDA is -0.60.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Iterum Therapeutics Plc 50-day moving average is $1.53.

Iterum Therapeutics Plc has 14 employees.